Research & Literature

Recommendations for evaluation and management of bone disease in HIV.

Brown TT, Hoy J, Borderi M, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; (60(8)):1242-51 doi:10.1093/cid/civ010.

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.

Mills A, Crofoot G, McDonald C, et al.

Journal of acquired immune deficiency syndromes (1999) 2015; (69(4)):439-45 doi:10.1097/QAI.0000000000000618.

Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.

Jabs DA, Ahuja A, Van Natta ML, et al.

Ophthalmology 2015; (122(7)):1452-63.

Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.

Haberer JE, Musinguzi N, Boum Y, et al.

Journal of acquired immune deficiency syndromes (1999) 2015; (70(4)):386-92 doi:10.1097/QAI.0000000000000737.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

, Lundgren JD, Babiker AG, et al.

The New England journal of medicine 2015; (373(9)):795-807 doi:10.1056/NEJMoa1506816.

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.

Gu L, Han Y, Li Y, et al.

PloS one 2015; (10(8)):e0134539 doi:10.1371/journal.pone.0134539.

Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions.

Tasaka S

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine 2015; (9(Suppl 1)):19-28 doi:10.4137/CCRPM.S23324.

Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm3.

Sidhu VK, Foisy MM, Hughes CA

The Annals of pharmacotherapy 2015; (49(12)):1343-8 doi:10.1177/1060028015605113.

Blood-Derived CD4 T Cells Naturally Resist Pyroptosis during Abortive HIV-1 Infection.

Muñoz-Arias I, Doitsh G, Yang Z, et al.

Cell host & microbe 2015; (18(4)):463-70.

Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.

Glass TR, Sterne JA, Schneider MP, et al.

AIDS (London, England) 2015; (29(16)):2195-200 doi:10.1097/QAD.0000000000000782.

[The clinical characteristics of twenty-five cases of acute HIV-1 infection in China].

Li N, Guo F, Li G, et al.

Zhonghua nei ke za zhi 2015; (54(10)):846-50.

Evaluation of Xpert HIV-1 Qual assay for resolution of HIV-1 infection in samples with negative or indeterminate Geenius HIV-1/2 results.

Michaeli M, Wax M, Gozlan Y, et al.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016; (76()):1-3.

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, et al.

The lancet. HIV 2016; (3(1)):e23-32.

Screening Yield of HIV Antigen/Antibody Combination and Pooled HIV RNA Testing for Acute HIV Infection in a High-Prevalence Population.

Peters PJ, Westheimer E, Cohen S, et al.

JAMA 2016; (315(7)):682-90 doi:10.1001/jama.2016.0286.

Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.

Caby F, Guihot A, Lambert-Niclot S, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; (62(10)):1297-1303 doi:10.1093/cid/ciw076.

Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution.

Alexander TS

Clinical and vaccine immunology : CVI 2016; (23(4)):249-53 doi:10.1128/CVI.00053-16.

T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.

Cobos Jiménez V, Wit FW, Joerink M, et al.

The Journal of infectious diseases 2016; (214(2)):216-25 doi:10.1093/infdis/jiw146.

Care of Patients With HIV Infection: Medical Complications and Comorbidities.

Bolduc P, Roder N, Colgate E, Cheeseman SH

FP essentials 2016; (443()):16-22.

HIV infection.

Deeks SG, Overbaugh J, Phillips A, Buchbinder S

Nature reviews. Disease primers 2015; (1()):15035 doi:10.1038/nrdp.2015.35.

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Robb ML, Eller LA, Kibuuka H, et al.

The New England journal of medicine 2016; (374(22)):2120-30 doi:10.1056/NEJMoa1508952.

Prevalence of Oro-Facial Lesions in Human Immunodeficiency Virus Infected Women in a Nigerian Teaching Hospital.

Okoh M, Saheeb BD, Agbelusi GA, Omoregie OF

Nigerian quarterly journal of hospital medicine 2013; (23(4)):251-6.

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Rodger AJ, Cambiano V, Bruun T, et al.

JAMA 2016; (316(2)):171-81 doi:10.1001/jama.2016.5148.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Günthard HF, Saag MS, Benson CA, et al.

JAMA 2016; (316(2)):191-210 doi:10.1001/jama.2016.8900.

Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses.

Rueda S, Mitra S, Chen S, et al.

BMJ open 2016; (6(7)):e011453 doi:10.1136/bmjopen-2016-011453.

Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Cohen MS, Chen YQ, McCauley M, et al.

The New England journal of medicine 2016; (375(9)):830-9 doi:10.1056/NEJMoa1600693.

The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis.

Tominski D, Katchanov J, Driesch D, et al.

HIV medicine 2017; (18(2)):125-132 doi:10.1111/hiv.12403.

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.

Klein MB, Althoff KN, Jing Y, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; (63(9)):1160-1167 doi:10.1093/cid/ciw531.

Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.

Buchacz K, Lau B, Jing Y, et al.

The Journal of infectious diseases 2016; (214(6)):862-72 doi:10.1093/infdis/jiw085.

Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients.

Lin X, Garg S, Mattson CL, et al.

Journal of the International Association of Providers of AIDS Care 2016; (15(6)):455-458 doi:10.1177/2325957416667486.

Review of cytomegalovirus coinfection in HIV-infected individuals in Africa.

Grønborg HL, Jespersen S, Hønge BL, et al.

Reviews in medical virology 2017; (27(1)) doi:10.1002/rmv.1907.

Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure.

Delaney KP, Hanson DL, Masciotra S, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (64(1)):53-59 doi:10.1093/cid/ciw666.

HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment.

Bowen LN, Smith B, Reich D, et al.

Nature reviews. Neurology 2016; (12(11)):662-674 doi:10.1038/nrneurol.2016.149.

Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Williamson PR, Jarvis JN, Panackal AA, et al.

Nature reviews. Neurology 2017; (13(1)):13-24 doi:10.1038/nrneurol.2016.167.

Screening for Cancer in Persons Living with HIV Infection.

Goedert JJ, Hosgood HD, Biggar RJ, et al.

Trends in cancer 2016; (2(8)):416-428 doi:10.1016/j.trecan.2016.06.007.

Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.

Lecher S, Williams J, Fonjungo PN, et al.

MMWR. Morbidity and mortality weekly report 2016; (65(47)):1332-1335 doi:10.15585/mmwr.mm6547a2.

HIV-Associated Urogenital Malignancies.

Hentrich M, Pfister D

Oncology research and treatment 2017; (40(3)):106-112 doi:10.1159/000457130.

Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.

Chiu CG, Smith D, Salters KA, et al.

BMC cancer 2017; (17(1)):270 doi:10.1186/s12885-017-3229-1.

Human immunodeficiency virus: Diagnostic approach.

Guarner J

Seminars in diagnostic pathology 2017; (34(4)):318-324 doi:10.1053/j.semdp.2017.04.008.

Should We Be Testing for Baseline Integrase Resistance in Patients Newly Diagnosed With Human Immunodeficiency Virus?

Koullias Y, Sax PE, Fields NF, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (65(8)):1274-1281 doi:10.1093/cid/cix542.

Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992-2015.

Collins LF, Clement ME, Stout JE

Open forum infectious diseases 2017; (4(3)):ofx120 doi:10.1093/ofid/ofx120.

Primary HIV Infection: Clinical Presentation, Testing, and Treatment.

Henn A, Flateau C, Gallien S

Current infectious disease reports 2017; (19(10)):37 doi:10.1007/s11908-017-0588-3.

Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.

Kooij KW, Vogt L, Wit FWNM, et al.

The Journal of infectious diseases 2017; (216(6)):622-631 doi:10.1093/infdis/jix202.

Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.

Crowell TA, Colby DJ, Pinyakorn S, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018; (66(10)):1540-1549 doi:10.1093/cid/cix1063.

Impact of alternative treatment approach for cerebral toxoplasmosis among HIV/AIDS patients from a resource-poor setting in Burkina Faso

Bamba S, Zoungrana J, Nikièma Z, et al.

Annals of parasitology 2017; (63(3)):173–181 doi:10.17420/ap6303.103.

The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients.

Anyimadu H, Pingili C, Sivapalan V, et al.

Journal of the International Association of Providers of AIDS Care 2018; (17()):2325958218759199 doi:10.1177/2325958218759199.

Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.

Kroeze S, Ondoa P, Kityo CM, et al.

AIDS (London, England) 2018; (32(8)):1043-1051 doi:10.1097/QAD.0000000000001801.

A Case of Jejunal Intussusception caused by Burkitt Lymphoma in an Acquired Immunodeficiency Syndrome Patient.

Baek DY, Heo DH, Oh SM, et al.

Infection & chemotherapy 2018; (50(1)):51-54 doi:10.3947/ic.2018.50.1.51.

Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis.

Shah ASV, Stelzle D, Lee KK, et al.

Circulation 2018; (138(11)):1100-1112 doi:10.1161/CIRCULATIONAHA.117.033369.

Fatal Disseminated Kaposi's Sarcoma in Two Patients with Human Immunodeficiency Virus (HIV) Infection.

Fardin RB, Leite LAC, Bezerra LMDS, et al.

The American journal of case reports 2018; (19()):868-874 doi:10.12659/AJCR.910004.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Saag MS, Benson CA, Gandhi RT, et al.

JAMA 2018; (320(4)):379-396 doi:10.1001/jama.2018.8431.

AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan.

Lee CY, Tseng YT, Lin WR, et al.

BMC infectious diseases 2018; (18(1)):352 doi:10.1186/s12879-018-3251-1.

Weight loss might be an early clinical feature of undiagnosed human immunodeficiency virus infection in Taiwan.

Lai SW, Lin CL, Liao KF

BioMedicine 2018; (8(3)):19 doi:10.1051/bmdcn/2018080319.

Optimizing antiretroviral regimens in chronic kidney disease.

Hamzah L, Jones R, Post FA

Current opinion in infectious diseases 2019; (32(1)):1-7 doi:10.1097/QCO.0000000000000509.

HIV infection/AIDS.

Tsukada K

Nihon rinsho. Japanese journal of clinical medicine 2016; (74(12)):1992-1997.

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.

Biver E, Calmy A, Aubry-Rozier B, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(5)):1125-1135 doi:10.1007/s00198-018-4794-0.

Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.

Wang DM, Liao Y, Li QF, et al.

Chinese medical journal 2019; (132(11)):1293-1297 doi:10.1097/CM9.0000000000000235.

The 2018 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.

Infection & chemotherapy 2019; (51(1)):77-88 doi:10.3947/ic.2019.51.1.77.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger AJ, Cambiano V, Bruun T, et al.

Lancet (London, England) 2019; (393(10189)):2428-2438 doi:10.1016/S0140-6736(19)30418-0.

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.

Feinstein MJ, Hsue PY, Benjamin LA, et al.

Circulation 2019; (140(2)):e98-e124 doi:10.1161/CIR.0000000000000695.

Imbalance of antioxidant enzymes activities and trace elements levels in Ghanaian HIV-infected patients.

Quaye O, Kuleape JA, Bonney EY, et al.

PloS one 2019; (14(7)):e0220181 doi:10.1371/journal.pone.0220181.

Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.

Engelman AN

The Journal of biological chemistry 2019; (294(41)):15137-15157 doi:10.1074/jbc.REV119.006901.

Late presentation among patients with human immunodeficiency virus infection in Turkey.

Karaosmanoğlu HK, Mete B, Gündüz A, et al.

Central European journal of public health 2019; (27(3)):229-234 doi:10.21101/cejph.a5416.

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.

Sax PE, Erlandson KM, Lake JE, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (71(6)):1379-1389 doi:10.1093/cid/ciz999.

Epidemiological characteristics of HIV infected Korean: Korea HIV/AIDS Cohort Study.

Choi Y, Choi BY, Kim SM, et al.

Epidemiology and health 2019; (41()):e2019037 doi:10.4178/epih.e2019037.

Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care.

Koofhethile CK, Moyo S, Kotokwe KP, et al.

Medicine 2019; (98(47)):e18014 doi:10.1097/MD.0000000000018014.

The Utility of Digital Anal Rectal Examinations in a Public Health Screening Program for Anal Cancer.

Nyitray AG, D'Souza G, Stier EA, et al.

Journal of lower genital tract disease 2020; (24(2)):192-196 doi:10.1097/LGT.0000000000000508.

Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: A meta-analysis of randomized controlled trials.

Tao X, Lu Y, Zhou Y, et al.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020; (93()):108-117 doi:10.1016/j.ijid.2020.01.035.

Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update.

Lee YT, Chuang ML

Journal of infection in developing countries 2018; (12(10)):824-834 doi:10.3855/jidc.10357.

Management of HIV-infected patients in the intensive care unit.

Barbier F, Mer M, Szychowiak P, et al.

Intensive care medicine 2020; (46(2)):329-342 doi:10.1007/s00134-020-05945-3.

Advances in Developing CAR T-Cell Therapy for HIV Cure.

Qi J, Ding C, Jiang X, Gao Y

Frontiers in immunology 2020; (11()):361 doi:10.3389/fimmu.2020.00361.

Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study.

Shoko C, Chikobvu D, Bessong PO

Pakistan journal of biological sciences : PJBS 2020; (23(4)):542-551 doi:10.3923/pjbs.2020.542.551.

Trends in Time From HIV Diagnosis to First Viral Suppression Following Revised US HIV Treatment Guidelines, 2012-2017.

Crepaz N, Song R, Lyss S, Hall HI

Journal of acquired immune deficiency syndromes (1999) 2020; (85(1)):46-50 doi:10.1097/QAI.0000000000002398.

Profile of new HIV diagnoses and risk factors associated with late diagnosis in a specialized outpatient clinic during the 2014-2018 period.

Palacios-Baena ZR, Martín-Ortega M, Ríos-Villegas MJ

Medicina clinica 2020; (155(11)):482-487 doi:10.1016/j.medcli.2020.01.035.

Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE.

Atkinson A, Zwahlen M, Barger D, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (73(2)):195-202 doi:10.1093/cid/ciaa615.

Close-up: HIV/SIV intasome structures shed new light on integrase inhibitor binding and viral escape mechanisms.

Engelman AN, Cherepanov P

The FEBS journal 2021; (288(2)):427-433 doi:10.1111/febs.15438.

Opportunistic parasitic infections in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: A review.

Laksemi DA, Suwanti LT, Mufasirin M, et al.

Veterinary world 2019; (13(4)):716-725 doi:10.14202/vetworld.2020.716-725.

HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir.

Rock AE, DeMarais PL, Vergara-Rodriguez PT, Max BE

Infectious diseases and therapy 2020; (9(3)):691-696 doi:10.1007/s40121-020-00307-4.

The Epidemiology of HIV Among People Born Outside the United States, 2010-2017.

Kerani RP, Satcher Johnson A, Buskin SE, et al.

Public health reports (Washington, D.C. : 1974) 2020; (135(5)):611-620 doi:10.1177/0033354920942623.

A Rare Case of Multipathogenic Pneumonia in a Patient With Human Immunodeficiency Virus.

Al-Shyoukh A, Younis M, Warsame M, Gohar A

Cureus 2020; (12(7)):e9307 doi:10.7759/cureus.9307.

Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.

Leeme TB, Mine M, Lechiile K, et al.

HIV medicine 2021; (22(1)):1-10 doi:10.1111/hiv.12951.

Determinants of suboptimal CD4+ T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV-1 infection.

Handoko R, Colby DJ, Kroon E, et al.

Journal of the International AIDS Society 2020; (23(9)):e25585 doi:10.1002/jia2.25585.

Intracranial Mass Lesions in Human Immunodeficiency Virus Patients in the Philippines: A Retrospective Cohort Study.

Omar AT, Nepomuceno MJ, Salvana EMT, Chua AE

World neurosurgery 2021; (145()):e149-e154 doi:10.1016/j.wneu.2020.09.141.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

Saag MS, Gandhi RT, Hoy JF, et al.

JAMA 2020; (324(16)):1651-1669 doi:10.1001/jama.2020.17025.

Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis.

Lailulo Y, Kitenge M, Jaffer S, et al.

Systematic reviews 2020; (9(1)):292 doi:10.1186/s13643-020-01524-1.

Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine.

Hodge D, Back DJ, Gibbons S, et al.

Clinical pharmacokinetics 2021; (60(7)):835-853 doi:10.1007/s40262-021-01005-1.

Pneumocystis jirovecii: a review with a focus on prevention and treatment.

Weyant RB, Kabbani D, Doucette K, et al.

Expert opinion on pharmacotherapy 2021; (22(12)):1579-1592 doi:10.1080/14656566.2021.1915989.

Use of dietary supplements containing polyvalent cations and antacids among people with HIV and its impact on viral suppression.

Peng AT, Huang SH, Sun HY, et al.

AIDS (London, England) 2021; (35(12)):2054-2057 doi:10.1097/QAD.0000000000002967.

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.

Atkinson A, Miro JM, Mocroft A, et al.

Journal of the International AIDS Society 2021; (24(6)):e25726 doi:10.1002/jia2.25726.

Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.

McClung RP, Oster AM, Ocfemia MCB, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (74(6)):1055-1062 doi:10.1093/cid/ciab583.

The first report of kidney transplantation in a human immunodeficiency virus-positive recipient in Thailand and literature review: Encouragement for developing countries in Southeast Asia.

Udomkarnjananun S, Naiyarakseree N, Townamchai N, et al.

SAGE open medical case reports 2021; (9()):2050313X211024471 doi:10.1177/2050313X211024471.

Acute HIV infection with presentations mimicking acalculous cholecystitis: A case report.

Liu WD, Cheng CN, Lin YT, et al.

Medicine 2021; (100(28)):e26653 doi:10.1097/MD.0000000000026653.

The intersection of drug interactions and adverse reactions in contemporary antiretroviral therapy.

Nhean S, Tseng A, Back D

Current opinion in HIV and AIDS 2021; (16(6)):292-302 doi:10.1097/COH.0000000000000701.

Participatory Prototyping of a Tailored Undetectable Equals Untransmittable Message to Increase HIV Testing Among Men in Western Cape, South Africa.

Smith PJ, Joseph Davey DL, Schmucker L, et al.

AIDS patient care and STDs 2021; (35(11)):428-434 doi:10.1089/apc.2021.0101.

Pharmacokinetic drug interactions of integrase strand transfer inhibitors.

Lu CH, Bednarczyk EM, Catanzaro LM, et al.

Current research in pharmacology and drug discovery 2021; (2()):100044 doi:10.1016/j.crphar.2021.100044.

Weight Changes With Integrase Strand Transfer Inhibitor Therapy in the Management of HIV Infection: A Systematic Review.

Hester EK, Greenlee S, Durham SH

The Annals of pharmacotherapy 2022; 10600280211073321 doi:10.1177/10600280211073321.

Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression.

Chen L, Liu CH, Kang S, et al.

BMC infectious diseases 2022; (22(1)):137 doi:10.1186/s12879-022-07113-y.

CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.

Jasinska AJ, Pandrea I, Apetrei C

Frontiers in immunology 2022; (13()):835994 doi:10.3389/fimmu.2022.835994.

Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.

Hawkins C, Kang M, Bhattacharya D, et al.

AIDS (London, England) 2022; (36(7)):975-984 doi:10.1097/QAD.0000000000003193.

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.

Palefsky JM, Lee JY, Jay N, et al.

The New England journal of medicine 2022; (386(24)):2273-2282 doi:10.1056/NEJMoa2201048.

Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study.

Sarowar A, Coffin CS, Fung S, et al.

Journal of acquired immune deficiency syndromes (1999) 2022; (91(4)):368-372 doi:10.1097/QAI.0000000000003079.

Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study.

Bettonte S, Berton M, Stader F, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023; (76(7)):1225-1236 doi:10.1093/cid/ciac901.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

Gandhi RT, Bedimo R, Hoy JF, et al.

JAMA 2023; (329(1)):63-84 doi:10.1001/jama.2022.22246.

A More Comprehensive Clinical and Laboratory Characterization of 61 Acute HIV Infection Patients in Southwest China.

Shi W, Yang M, Wei Y, et al.

Pathogens (Basel, Switzerland) 2023; (12(1)) doi:10.3390/pathogens12010142.

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.

Grinspoon SK, Fitch KV, Zanni MV, et al.

The New England journal of medicine 2023; (389(8)):687-699 doi:10.1056/NEJMoa2304146.

HIV-1-Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities.

Moretti S, Schietroma I, Sberna G, et al.

International journal of molecular sciences 2023; (24(15)) doi:10.3390/ijms241512193.

Prevalence of hypertension and diabetes and associated risk factors among people living with human immunodeficiency virus in Southern Ethiopia.

Badacho AS, Mahomed OH

Frontiers in cardiovascular medicine 2023; (10()):1173440 doi:10.3389/fcvm.2023.1173440.

Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia.

Lui GC, Wong GL, Yang HC, et al.

HIV medicine 2023; (24(10)):1035-1044 doi:10.1111/hiv.13545.

The impact of anxiety, depression, and social support on the relationship between HIV-related stigma and mental health-related quality of life among Chinese patients: a cross-sectional, moderate-mediation study.

Zhang Y, Chai C, Xiong J, et al.

BMC psychiatry 2023; (23(1)):818 doi:10.1186/s12888-023-05103-1.

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.

Sension MG, Brunet L, Hsu RK, et al.

Infectious diseases and therapy 2023; (12(12)):2807-2817 doi:10.1007/s40121-023-00890-2.

Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing.

Dawe J, Cassano D, Keane R, et al.

HIV medicine 2023; (24(12)):1253-1267 doi:10.1111/hiv.13592.

Tenofovir-Induced Fanconi Syndrome Presenting with Life-Threatening Hypokalemia: Review of the Literature and Recommendations for Early Detection.

Liatsou E, Tatouli I, Mpozikas A, et al.

Journal of clinical medicine 2023; (12(22)) doi:10.3390/jcm12227178.

Antibiotic prophylaxis in immunosuppressed patients - Missed opportunities from trimethoprim-sulfamethoxazole allergy label.

Lee WI, Lam L, Bacchi S, et al.

The World Allergy Organization journal 2024; (17(1)):100856 doi:10.1016/j.waojou.2023.100856.

One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study.

Muccini C, Gianotti N, Diotallevi S, et al.

Open forum infectious diseases 2024; (11(7)):ofae326 doi:10.1093/ofid/ofae326.

Cutaneous Pneumocystis Jirovecii Infection in an Allogeneic Stem Cell Transplant Recipient.

Sood N, Vadnerkar A, Kodali M, Hamacher LK

European journal of case reports in internal medicine 2024; (11(7)):004615 doi:10.12890/2024_004615.

Ocular involvement in highly treatment-experienced patients with HIV.

Cobaschi M, Dorobăț CM, Dorobăț VD, et al.

Romanian journal of ophthalmology 2024; (68(2)):152-157 doi:10.22336/rjo.2024.28.

Virologic Failure and Emergent Integrase Strand Transfer Inhibitor Drug Resistance With Long-Acting Cabotegravir for HIV Treatment: A Meta-analysis.

Perez Navarro A, Nutt CT, Siedner MJ, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025; (81(2)):274-285 doi:10.1093/cid/ciae631.

Prevalence of advanced HIV disease in sub-Saharan Africa: a multi-country analysis of nationally representative household surveys.

Stelzle D, Rangaraj A, Jarvis JN, et al.

The Lancet. Global health 2025; (13(3)):e437-e446 doi:10.1016/S2214-109X(24)00538-2.

Addressing Cardiometabolic Challenges in HIV: Insights, Impact, and Best Practices for Optimal Management-A Narrative Review.

Mugisha N, Ghanem L, Komi OAI, et al.

Health science reports 2025; (8(4)):e70727 doi:10.1002/hsr2.70727.

Eligibility for Intramuscular Cabotegravir/Rilpivirine in HIV-Positive Patients: An Observational Study.

Martínez-Orea G, Rodríguez-Lucena FJ, Fuentes-Hidalgo F, et al.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 2025; (41(4)):159-164 doi:10.1177/87551225251333698.

Non-acquired immunodeficiency syndrome-related cryptococcal meningitis with recurrent acute stroke: A case report.

Ye B, Wu J, Qiu Y, et al.

The Journal of international medical research 2025; (53(6)):3000605251350976 doi:10.1177/03000605251350976.

Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.

Llibre JM, Ripamonti D, Geretti AM, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026; (82(5)):785-798 doi:10.1093/cid/ciaf471.

The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study.

Han N, Loosli T, Anderegg N, et al.

The Lancet. Global health 2025; (13(12)):e2133-e2143 doi:10.1016/S2214-109X(25)00350-X.

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.

Behrens GMN, Assoumou L, Liegeon G, et al.

The Lancet. Infectious diseases 2026; (26(5)):510-521 doi:10.1016/S1473-3099(25)00681-4.

HIV-1 3΄ polypurine tract mutations and integrase inhibitor resistance.

Bishop MD, Xu L, Boyce CL, et al.

AIDS (London, England) 2025; (39(14)):1996-2013 doi:10.1097/QAD.0000000000004315.

Attitudes, Knowledge, and Worry About HIV in the U=U Era: A Campaign with Before-After Surveys Among HIV-Negative Men Who Have Sex with Men in Sweden.

Sjöland CF, Dennermalm N, Nilsson Schönnesson L, et al.

AIDS and behavior 2026; (30(6)):1699-1712 doi:10.1007/s10461-025-04972-9.

Declining prevalence of AIDS-defining illness among newly diagnosed people living with HIV in northern Thailand: a 10-year review.

Srijiranon D, Wongsarikan N, Chaiwarith R

BMC infectious diseases 2026; (26(1)).

HIV and Hickam's Dictum: Multiple Opportunistic Infections.

Patel P, Rampersad A, Alden J, et al.

ACG case reports journal 2026; (13(5)):e02100 doi:10.14309/crj.0000000000002100.

Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and Canada.

Bourgi K, Bian A, Boyd L, et al.

The Journal of infectious diseases 2026; doi:10.1093/infdis/jiag271.

Partial pupil-sparing third nerve palsy as a manifestation of cerebral toxoplasmosis in an HIV-positive patient: A case report.

Aljohani HA, Alzahrani AS, Alrashid AS, Tuwair I

American journal of ophthalmology case reports 2026; (43()):102602 doi:10.1016/j.ajoc.2026.102602.

Five-Year Immune Recovery After ART Initiation Among PLWH Aged ≥15 Years with Baseline Immunosuppression - China, 2013-2024.

Geng Y, Jia H, Guan Y, et al.

China CDC weekly 2026; (8(25)):772-779 doi:10.46234/ccdcw2026.125.

Immune Dysregulation and Viral Persistence in HPV-HIV Coinfection: Oncogenic and Clinical Implications.

Sadrkhanlou M, Nasouti Aghjehroud H, Nikkhooy Z, et al.

HIV/AIDS (Auckland, N.Z.) 2026; (18()):616942 doi:10.2147/HIV.S616942.